BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18992012)

  • 1. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
    Holmlund C; Haapasalo H; Yi W; Raheem O; Brännström T; Bragge H; Henriksson R; Hedman H
    Neuropathology; 2009 Jun; 29(3):242-7. PubMed ID: 18992012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
    Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
    Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
    Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
    Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
    Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
    J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
    Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
    Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRIG and cancer prognosis.
    Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
    Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
    Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
    PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
    Wu X; Hedman H; Bergqvist M; Bergström S; Henriksson R; Gullbo J; Lennartsson J; Hesselius P; Ekman S
    Acta Oncol; 2012 Jan; 51(1):69-76. PubMed ID: 21417672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea.
    Guo D; Holmlund C; Henriksson R; Hedman H
    Genomics; 2004 Jul; 84(1):157-65. PubMed ID: 15203213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
    Del Rio T; Nishitani AM; Yu WM; Goodrich LV
    PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redistribution of LRIG proteins in psoriasis.
    Karlsson T; Mark EB; Henriksson R; Hedman H
    J Invest Dermatol; 2008 May; 128(5):1192-5. PubMed ID: 18037903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendroglioma: CD44 as a possible prognostic opportunity.
    Buccoliero AM; Caldarella A; Arganini L; Mennonna P; Ammanati F; Taddei A; Taddei GL
    Clin Neuropathol; 2003; 22(4):169-75. PubMed ID: 12908752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.
    Ranhem C; Lillsunde Larsson G; Hedman H; Lindquist D; Karlsson MG; Hellström AC; Östensson E; Sorbe B; Hellman K; Andersson S
    PLoS One; 2017; 12(8):e0183816. PubMed ID: 28841699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
    Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
    Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oligodendroglioma. Clinical course in relation to histological grading].
    Neumann J; Kimpel J; Gulotta F
    Neurochirurgia (Stuttg); 1978 Mar; 21(2):35-42. PubMed ID: 643146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.
    Malik U; Javed A
    Curr Cancer Drug Targets; 2017; 17(1):3-16. PubMed ID: 27628597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
    Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
    Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
    Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.